老年结直肠癌病人化疗耐受性的影响因素分析

doi:10.3969/j.issn.1003-9198.2023.05.016

摘要/Abstract

摘要： 目的探讨影响老年结直肠癌病人化疗耐受性的影响因素,以期为筛选适合化疗的老年肿瘤病人提供一定的依据。方法回顾性分析我院2017~2021年间154例被诊断为结直肠癌且接受化疗的老年病人(年龄≥65岁),以其化疗结果分为化疗耐受良好、化疗基本耐受、化疗不耐受3组,比较3组病人的基础情况、肿瘤情况、营养状况、情感状况、治疗情况等,并以化疗耐受良好为一组,剩余病人为另一组,采用Logistic回归分析影响老年结直肠癌病人化疗耐受性的独立危险因素。结果 154例病人中,108例病人化疗耐受良好,27例病人化疗基本耐受,19例病人化疗不耐受。单因素分析提示:各组间年龄、基础疾病数量、肿瘤部位、临床分期、治疗方式、体力状况(PS)评分、营养状况、抑郁状态以及化疗前PLT、Hb、前白蛋白、白蛋白、癌胚抗原(CEA)水平差异有统计学意义。Logistic回归分析显示,肿瘤部位、临床分期、治疗方式、PS评分、营养状况、抑郁状态、Hb、白蛋白、CEA为化疗耐受差的独立影响因素。结论老年结直肠癌病人也应得到积极抗癌治疗,化疗作为主要的抗癌治疗手段,不应以年龄作为简单的判断,Hb、白蛋白、CEA作为化疗耐受性差的独立影响因素可作为有效的参考指标。同时,肿瘤部位、临床分期、治疗方式、PS评分、营养状况、是否抑郁作为独立影响因素也需考虑在内。

关键词: 结直肠癌, 化疗耐受性, 老年人

Abstract: Objective To explore the influencing factors of chemotherapy tolerance in the elderly patients with colorectal cancer, in order to provide basis for screening elderly patients suitable for chemotherapy. Methods A retrospective study was conducted among 154 elderly patients(aged ≥65 years) who were diagnosed as colorectal cancer and received chemotherapy from 2017 to 2021, and the patients were divided into good chemotherapy tolerance group, basic chemotherapy tolerance group, and chemotherapy intolerance group according to the chemotherapy outcomes. The basic conditions, tumor conditions, nutritional status, emotional conditions and treatment conditions were compared in the three groups. Multivariate regression analysis was further performed to analyze the independent risk factors of chemotherapy tolerance in the elderly patients with colorectal cancer. Results Among 154 patients, 108 presented with good chemotherapy tolerance, 27 with basic chemotherapy tolerance (70.2%) and 19 with chemotherapy intolerance. Single factor analysis showed that age, number of basic diseases, tumor site, clinical stage, treatment mode, Performance Status(PS)Score, nutritional status, depression, and the levels of platelet, hemoglobin(Hb), prealbumin, albumin and carcinoembryonic antigen(CEA) were significantly different among the groups. Logistic regression analysis showed that tumor site, clinical stage, treatment mode, PS score, nutritional status, depression, Hb, albumin, and CEA were the independent influcencing factors for poor chemotherapy tolerance. Conclusions Elderly patients with colorectal cancer should receive active anti-cancer treatment. Chemotherapy as the main anti-cancer treatment should not be judged simply by age. Hb, albumin and CEA can be used as predictive indicators for prognosis. At the same time, tumor site, clinical stage, treatment mode, PS score, nutritional status and depression should also be considered as the independent influencing factors.

Key words: colorectal cancer, chemotherapy tolerance, aged

中图分类号:

R 735.35

邓仕超, 沈浩, 孙强, 陈佳栋, 马保金. 老年结直肠癌病人化疗耐受性的影响因素分析[J]. 实用老年医学, 2023, 37(5): 500-504.

DENG Shi-chao, SHEN Hao, SUN Qiang, CHEN Jia-dong, MA Bao-jin. Analysis of influencing factors of chemotherapy tolerance in elderly patients with colorectal cancer[J]. Practical Geriatrics, 2023, 37(5): 500-504.

参考文献

[1] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics,2021[J].CA Cancer J Clin, 2021, 71(1):7-33.
[2] SIEGEL R L, MILLER K D, GODING SAUER A, et al. Colorectal cancer statistics, 2020[J].CA Cancer J Clin, 2020, 70(3):145-164.
[3] KIM J H. Chemotherapy for colorectal cancer in the elderly[J].World J Gastroenterol, 2015, 21(17):5158-5166.
[4] ITATANI Y, KAWADA K, SAKAI Y. Treatment of elderly patients with colorectal cancer[J].Biomed Res Int, 2018, 2018:2176056.
[5] PUPWE G, NGALAMIKA O, AKUDUGU J. Chemotherapy for elderly colorectal cancer patients at a tertiary hospital in South Africa[J]. Pan Afr Med J, 2020, 37:100.
[6] YAP R, OLIVA K, WILKINS S, et al. Colorectal cancer surgery in the very elderly: nonagenarians[J].Dis Colon Rectum, 2016, 59(6):501-507.
[7] KOTAKE K, ASANO M, OZAWA H, et al.Tumor characteristics, treatment patterns and survival of patients aged 80 years or older with colorectal cancer[J].Colorectal Dis, 2015, 17(3):205-215.
[8] SAKIN A, YASAR N, SAHIN S, et al.Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: an observational study[J].J Oncol Pharm Pract, 2020, 26(3):619-631.
[9] CHEN W, DONG H, WANG G, et al. Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study[J]. World J Surg Oncol, 2021, 19(1):238.
[10] LIN Y M, WANG M, SUN N X, et al. Screening and application of nutritional support in elderly hospitalized patients of a tertiary care hospital in China[J].PLoS One, 2019, 14(3):e0213076.
[11] GABRIELSON D K, BREZDEN-MASLEY C, KEITH M, et al. Evaluation of nutritional inflammatory and fatty acid status in patients with gastric and colorectal cancer receiving chemotherapy[J]. Nutr Cancer, 2021, 73(3):420-432.
[12] OGINO H, HANIBUCHI M, KAKIUCHI S, et al. Analysis of the prognostic factors of extensive disease small-cell lung cancer patients in Tokushima University Hospital[J]. J Med Invest, 2016, 63(3/4):286-293.
[13] AN M S, YOO J H, KIM K H, et al. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy[J].World J Surg Oncol, 2015, 13:64.
[14] XIE Y, HUANG Y, RUAN Q, et al. Impact of tumor site on lymph node status and survival in colon cancer[J]. J Cancer, 2019, 10(11):2376-2383.

[1]	丛晓飞, 李铭麟, 石春来. 老年口腔衰弱与多重用药的关系及干预策略[J]. 实用老年医学, 2024, 38(9): 872-875.
[2]	李毛毛, 张飞, 沈鑫, 李洁华. 老年人口腔衰弱与跌倒关系的研究进展[J]. 实用老年医学, 2024, 38(9): 876-879.
[3]	张飞, 李毛毛, 李铭麟, 王佳贺. 老年人口腔衰弱与抑郁症的相关性研究进展[J]. 实用老年医学, 2024, 38(9): 884-888.
[4]	李江, 邱雁, 王婷, 王丹, 虞一帆, 濮玲丽, 卜玲. 老年肺腺癌病人术前全身免疫炎症指数/血清白蛋白与临床病理特征的相关性研究[J]. 实用老年医学, 2024, 38(9): 893-896.
[5]	戴静, 崔焱. 糖化血红蛋白变异性与老年2型糖尿病病人认知功能障碍的相关性分析[J]. 实用老年医学, 2024, 38(9): 931-935.
[6]	张星星, 张海洋, 何小菁, 鲁翔. 不同肥胖指标与老年人糖尿病患病风险的调查研究[J]. 实用老年医学, 2024, 38(9): 940-943.
[7]	倪红艳, 陈云, 张其兵, 马一鸣, 解成兰. 电针对老年病人下肢骨科手术围术期认知功能及炎症因子的影响[J]. 实用老年医学, 2024, 38(9): 944-947.
[8]	李晓敏, 李晓林, 栗杰, 吴蕾, 郝冉冉. 老年病人经肛双气囊小肠镜进镜效率及其影响因素研究[J]. 实用老年医学, 2024, 38(9): 958-961.
[9]	蔡荟萃, 陈燕, 王燕, 叶劲军, 朱钰颖. 多形式健康教育模式联合简易呼吸功能锻炼对老年肺癌放疗病人癌因性疲乏及遵医行为的影响[J]. 实用老年医学, 2024, 38(9): 968-972.
[10]	李湘, 栗萱, 田应选. 肺衰老与慢性呼吸系统疾病研究现状及进展[J]. 实用老年医学, 2024, 38(8): 761-765.
[11]	王小娇, 王宁, 崔宏, 叶童, 王晓明. 运动康复对老年轻中度慢性心力衰竭病人的疗效评价[J]. 实用老年医学, 2024, 38(8): 775-778.
[12]	郝世杰, 邹建鹏, 卫晨, 刘清江. 综合呼吸训练对老年帕金森病病人运动减少型构音障碍的影响[J]. 实用老年医学, 2024, 38(8): 783-787.
[13]	向超, 罗彩东. 心电图avL导联T波变化对老年冠心病病人冠脉狭窄程度的诊断价值[J]. 实用老年医学, 2024, 38(8): 788-791.
[14]	李慧颖, 蔡力力, 朱启伟. 血浆N末端脑钠肽前体对高龄左室肥厚病人预后的预测价值[J]. 实用老年医学, 2024, 38(8): 797-801.
[15]	王新平, 谢柏梅, 卫国, 叶晓莉, 赵亚芸, 谭小田. 老年特发性间质性肺炎病人血清S100A9及sCD163表达水平及临床意义[J]. 实用老年医学, 2024, 38(8): 802-807.